112 related articles for article (PubMed ID: 1933611)
1. Serum vitamin D level after an annual intramuscular injection of ergocalciferol.
Heikinheimo RJ; Haavisto MV; Harju EJ; Inkovaara JA; Kaarela RH; Kolho LA; Rajala SA
Calcif Tissue Int; 1991; 49 Suppl():S87. PubMed ID: 1933611
[TBL] [Abstract][Full Text] [Related]
2. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
[TBL] [Abstract][Full Text] [Related]
3. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
5. Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.
Vande Griend JP; McQueen RB; Linnebur SA; Vondracek SF
Pharmacotherapy; 2012 Feb; 32(2):135-41. PubMed ID: 22392422
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
[TBL] [Abstract][Full Text] [Related]
8. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women.
Mueangpaisarn P; Chaiamnuay S
Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012
[TBL] [Abstract][Full Text] [Related]
9. Nutritional vitamin D supplementation in dialysis: a randomized trial.
Bhan I; Dobens D; Tamez H; Deferio JJ; Li YC; Warren HS; Ankers E; Wenger J; Tucker JK; Trottier C; Pathan F; Kalim S; Nigwekar SU; Thadhani R
Clin J Am Soc Nephrol; 2015 Apr; 10(4):611-9. PubMed ID: 25770176
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.
Pepper KJ; Judd SE; Nanes MS; Tangpricha V
Endocr Pract; 2009 Mar; 15(2):95-103. PubMed ID: 19342361
[TBL] [Abstract][Full Text] [Related]
11. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis.
Cipriani C; Romagnoli E; Pepe J; Russo S; Carlucci L; Piemonte S; Nieddu L; McMahon DJ; Singh R; Minisola S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2709-15. PubMed ID: 23766519
[TBL] [Abstract][Full Text] [Related]
12. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.
Boyle MP; Noschese ML; Watts SL; Davis ME; Stenner SE; Lechtzin N
Am J Respir Crit Care Med; 2005 Jul; 172(2):212-7. PubMed ID: 15860755
[TBL] [Abstract][Full Text] [Related]
13. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
Simoneau T; Sawicki GS; Milliren CE; Feldman HA; Gordon CM
J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
[TBL] [Abstract][Full Text] [Related]
15. Study of the Safe Dosage of Ergocalciferol.
Bunyaratavej N
J Med Assoc Thai; 2015 Sep; 98 Suppl 8():S13-5. PubMed ID: 26529808
[TBL] [Abstract][Full Text] [Related]
16. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
Melhem SJ; Aiedeh KM; Hadidi KA
Ann Saudi Med; 2015; 35(1):13-8. PubMed ID: 26142932
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?
Qunibi WY; Abdellatif A; Sankar S; Hamdan Z; Lin FY; Ingle J; Cadena A; Gelfond J; Kasinath B
Clin Nephrol; 2010 Apr; 73(4):276-85. PubMed ID: 20353735
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D deficiency and its correction in children with sickle cell anaemia.
Wykes C; Arasaretnam A; O'Driscoll S; Farnham L; Moniz C; Rees DC
Ann Hematol; 2014 Dec; 93(12):2051-6. PubMed ID: 24981689
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of intramuscular ergocalciferol treatment in a patient with osteomalacia and insufficiency fractures due to severe vitamin D deficiency after bariatric surgery.
Papanastasiou L; Gravvanis C; Tournis S; Markou A; Giagourta I; Lymperopoulos K; Kounadi T
J Musculoskelet Neuronal Interact; 2020 Jun; 20(2):291-296. PubMed ID: 32481245
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D replacement on insulin sensitivity in subjects with vitamin D deficiency.
Simha V; Mahmood M; Ansari M; Spellman CW; Shah P
J Investig Med; 2012 Dec; 60(8):1214-8. PubMed ID: 23111651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
